Indium-111 pentetreotide
Approved Use: Scintigraphic localization of primary and metastatic neuroendocrine tumors bearing somatostatin receptors
Dose: 3 mCi (planar), 6 mCi (SPECT)
Brand Name: Octreoscan™
Manufacturer: Curium
Package Insert
How Supplied: each kit contains:
Availability:
Dose: 3 mCi (planar), 6 mCi (SPECT)
Brand Name: Octreoscan™
Manufacturer: Curium
Package Insert
How Supplied: each kit contains:
- Octreoscan™ Reaction Vial (10µg pentetreotide, 2mg gentisic acid, 4.9mg trisodium citrate, 0.37mg citric acid, 10mg inositol)
- In-111 chloride vial (3.3mCi in 1.1cc)
- one 25 gauge 5/8" transfer needle (BD, Monoject)
- Friday @ 18:00 CT (3.3 mCi)
- Sunday @ 18:00 CT (3.3 mCi)
- In-111 chloride vial expires 1 day after calibration
- Reconstituted vial expires 6 hours from time of preparation
Availability:
- Friday calibrated material first available to ship Sunday for Monday delivery (4 days pre-cal)
- Sunday calibrated material first available to ship Tuesday for Wednesday delivery (4 days pre-cal)
In-111 Chloride Vial Activity Chart:
3.3 mCi on Friday @ 18:00 CT
3.3 mCi on Sunday @ 18:00 CT
3.3 mCi on Friday @ 18:00 CT
3.3 mCi on Sunday @ 18:00 CT
Day @06:00CT |
Friday Cal. Lot |
Sunday Cal. Lot |
Monday |
10.05 mCi |
- |
Tuesday |
7.85 mCi |
- |
Wednesday |
6.13 mCi |
10.05 mCi |
Thursday |
4.78 mCi |
7.85 mCi |
Friday |
3.74 mCi |
6.13 mCi |
Saturday |
- |
4.78 mCi |
Sunday |
- |
3.74 mCi |
Clinical Guidelines:
- ACR–ACNM–SNMMI–SPR Practice Parameter for the Performance of Neuroendocrine Tumor Scintigraphy (2020)
- EANM Practice Guideline/SNMMI Procedure Standard for Radionuclide Imaging of Pheochromocytoma and Paraganglioma (2019)
- ACR-SPR Practice Parameter for the Performance of Tumor Scintigraphy (2015)
- SNMMI Procedure Standard for Somatostatin Receptor Scintigraphy 2.0 (2011)